BRAEBURN PHARMACEUTICALS, INC.

Profile

Company Names

BRAEBURN PHARMACEUTICALS, INC.

Addresses

47 HULFISH STREET, SUITE 441, PRINCETON, NJ 08542

Phone Numbers

609-751-5375

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$110,003,471.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-01-08 
$110,003,471.00 
$110,003,471.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
BERKOWITZ 
DIRECTOR
HC GROUP HOLDINGS I, LLC   |  BRAEBURN PHARMACEUTICALS, INC.   |  PHANTOM PARENT, LP   |  CLICK THERAPEUTICS, INC.
MICHAEL 
 
DERKACZ 
EXECUTIVE OFFICER, DIRECTOR
BRAEBURN PHARMACEUTICALS, INC.
SETH 
L. 
HARRISON, M.D. 
EXECUTIVE OFFICER, DIRECTOR
BRAEBURN PHARMACEUTICALS, INC.
ARGERIS 
 
KARABELAS, PH.D. 
DIRECTOR
BRAEBURN PHARMACEUTICALS, INC.
PATRICK 
 
KENNEDY 
DIRECTOR
ZERO GRAVITY SOLUTIONS, INC.   |  MRO PARENT CORP   |  REMITDATA, INC.   |  QUARTET HEALTH, INC.   |  CLEANSLATE CENTERS, INC.   |  BRAEBURN PHARMACEUTICALS, INC.   |  HEALTHEC, LLC   |  QUARTET HEALTH HOLDINGS, INC.   |  AXIAL HEALTHCARE HOLDINGS, L.P.   |  BARN PRODUCTIONS, LLC
DENNIS 
H. 
LANGER, J. D., M.D. 
DIRECTOR
BRAEBURN PHARMACEUTICALS, INC.
BRIAN 
 
MARKISON 
DIRECTOR
ROSETTA GENOMICS LTD.   |  BRAEBURN PHARMACEUTICALS, INC.   |  ACP NIMBLE HOLDINGS, INC.   |  NATIONAL SPINE + PAIN CENTERS HOLDINGS, LLC   |  RVL PHARMACEUTICALS PLC
DAVID 
J. 
MCINTYRE 
EXECUTIVE OFFICER
BRAEBURN PHARMACEUTICALS, INC.
ASHER 
M. 
RUBIN 
EXECUTIVE OFFICER
BRAEBURN PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-01-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-01-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#